Analyst Profile

Followed by 60 followers
.
Josh Jennings

Josh Jennings

Cowen & Co.
Wall Street Analyst
#2,527 out of 8,170 Wall Street Analysts
#5,363 out of 24,551 experts

Success Rate

52%
152 out of 290 transactions made a profit

Average Return

+2.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Josh Jennings's trades since 2010 and holding each position for 1 Year would result in 52.41% of your transactions generating a profit, with an average return of 2.3% per rating.

Stock Rating Distribution

353Ratings
86.69% Buy
13.31% Hold
0.00% Sell
Distribution of Josh Jennings's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market

Best Rating

Stock:
Transmedics Group
(TMDX)
Rating:Buy
Date:Feb 24, 2022 - Today
Return:+268.50%
The most profitable rating made by Josh Jennings

Josh Jennings's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
~BEAT
BioTelemetry
Mar 10, 2010
Hold
Upgraded
1Ratings
0.00%
HNSN
Hansen Medical
Jun 28, 2013
Buy
Initiated
1Ratings
0%
-14.20%
IMRIS
Aug 30, 2013
Buy
Initiated
$3.50
(349999900.00% Upside)
1Ratings
0%
-59.00%
Nuwellis
Mar 18, 2015
Buy
Reiterated
$9.00
(7400.00% Upside)
1Ratings
0%
-76.60%
LDRH
LDR Holding
Jun 14, 2016
Hold
Downgraded
1Ratings
0.00%
STJ
St Jude Medical
Oct 11, 2016
Buy
Reiterated
5Ratings
67%
+11.07%
Avinger
Apr 11, 2017
Buy
Reiterated
$80.00
(6457.38% Upside)
1Ratings
0%
-94.70%
BCR
CR Bard
Apr 24, 2017
Hold
Reiterated
7Ratings
0.00%
Adynxx
Aug 10, 2017
Buy
Reiterated
$0.75
(749900.00% Upside)
1Ratings
0%
-10.10%
KTWO
K2M Group Holdings
Sep 04, 2018
Hold
Downgraded
8Ratings
71%
+17.10%
List of latest recommendations made by Josh Jennings. Click to expand and see Josh Jennings's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >